Abstract
Enterococcus faecalis infective endocarditis (IE) is a disease of increasing importance, with more patients infected, increasing frequency of health-care associated infections and increasing incidence of antimicrobial resistances. The typical clinical presentation is a subacute course with fever, malaise and generalized aches, difficult to distinguish from other more common diseases. Of paramount importance is transthoracic- and transesophageal-echocardiography to establish the diagnosis. At the moment, the predominant strategies recommend ampicillin in combination with either gentamicin or ceftriaxone. E. faecalis infective endocarditis continues to be a very serious disease with considerable percentages of high-level gentamicin resistant strains and in-hospital mortality around 20%. Strategies to prevent E. faecalis IE, improve diagnostics, optimize treatment and reduce morbidity will be necessary to improve the overall prognosis.
| Original language | English |
|---|---|
| Journal | Expert Review of Cardiovascular Therapy |
| Volume | 11 |
| Issue number | 9 |
| Pages (from-to) | 1247-57 |
| Number of pages | 11 |
| ISSN | 1477-9072 |
| DOIs | |
| Publication status | Published - Sept 2013 |
Keywords
- Ampicillin
- Anti-Bacterial Agents
- Ceftriaxone
- Drug Therapy, Combination
- Endocarditis, Bacterial
- Enterococcus faecalis
- Humans
Fingerprint
Dive into the research topics of 'Enterococcus faecalis infective endocarditis: focus on clinical aspects'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS